Literature DB >> 8382580

Beta 2-adrenoceptor desensitization in cultured human airway smooth muscle.

I P Hall1, K Daykin, S Widdop.   

Abstract

1. The mechanisms underlying control of cyclic AMP responses to isoprenaline were studied in primary cultures of human airway smooth muscle cells. In these cells, isoprenaline induced concentration-related cyclic AMP formation via beta 2-adrenoceptor stimulation. 2. Prior incubation of cells with varying concentrations of isoprenaline (1-16 h), forskolin, prostaglandin E2 or a stable analogue of cyclic AMP all produced concentration-related desensitization of cyclic AMP responses to subsequent challenge with isoprenaline (maximum reduction with 1 mumol/l isoprenaline, 85% after 16 h). The desensitization induced over 2 h (44%) by a concentration of prostaglandin E2 which gave a similar rise in cyclic AMP levels to 1 mumol/l isoprenaline was significantly less (P < 0.05) than the desensitization (62%) induced over 2 h by 1 mumol/l isoprenaline itself. 3. Isoprenaline-induced desensitization of beta 2-adrenoceptor-induced cyclic AMP formation was insensitive to prior exposure of cells to dexamethasone. 4. These findings suggest that isoprenaline-induced desensitization of beta 2-adrenoceptor-induced cyclic AMP formation in primary cultures of human airway smooth muscle cells is mediated through both a cyclic AMP-dependent and probably an additional cyclic AMP-independent pathway, and that these pathways are insensitive to inhibition by glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382580     DOI: 10.1042/cs0840151

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle.

Authors:  Stefano Fogli; Silvia Pellegrini; Barbara Adinolfi; Veronica Mariotti; Erika Melissari; Laura Betti; Laura Fabbrini; Gino Giannaccini; Antonio Lucacchini; Claudio Bardelli; Fabio Stefanelli; Sandra Brunelleschi; Maria Cristina Breschi
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

2.  Randomised placebo controlled trial of beta agonist dose reduction in asthma.

Authors:  T W Harrison; J Oborne; P J Wilding; A E Tattersfield
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

3.  Effects of a range of beta2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells.

Authors:  M G Scott; C Swan; T M Jobson; S Rees; I P Hall
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

4.  Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.

Authors:  I Sayers; J Hawley; C E Stewart; C K Billington; A Henry; J R Leighton-Davies; S J Charlton; I P Hall
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

5.  Airway smooth muscle relaxation results from a reduction in the frequency of Ca2+ oscillations induced by a cAMP-mediated inhibition of the IP3 receptor.

Authors:  Yan Bai; Michael J Sanderson
Journal:  Respir Res       Date:  2006-02-23

Review 6.  Signaling and regulation of G protein-coupled receptors in airway smooth muscle.

Authors:  Charlotte K Billington; Raymond B Penn
Journal:  Respir Res       Date:  2003-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.